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Abstract
Background: A unique and essential property of embryonic stem cells is the ability to self-renew and
differentiate into multiple cell lineages. However, the possible differences in proliferation and
differentiation capabilities among independently-derived human embryonic stem cells (hESCs) are not well
known because of insufficient characterization. To address this question, a side-by-side comparison of 1)
the ability to maintain an undifferentiated state and to self-renew under standard conditions; 2) the ability
to spontaneously differentiate into three primary embryonic germ lineages in differentiating embryoid
bodies; and 3) the responses to directed neural differentiation was made between three NIH registered
hES cell lines I3 (TE03), I6 (TE06) and BG01V. Lines I3 and I6 possess normal XX and a normal XY
karyotype while BG01V is a variant cell line with an abnormal karyotype derived from the karyotypically
normal cell line BG01.
Results: Using immunocytochemistry, flow cytometry, qRT-PCR and MPSS, we found that all three cell
lines actively proliferated and expressed similar "stemness" markers including transcription factors
POU5F1/Oct3/4 and NANOG, glycolipids SSEA4 and TRA-1-81, and alkaline phosphatase activity. All cell
lines differentiated into three embryonic germ lineages in embryoid bodies and into neural cell lineages
when cultured in neural differentiation medium. However, a profound variation in colony morphology,
growth rate, BrdU incorporation, and relative abundance of gene expression in undifferentiated and
differentiated states of the cell lines was observed. Undifferentiated I3 cells grew significantly slower but
their differentiation potential was greater than I6 and BG01V. Under the same neural differentiation-
promoting conditions, the ability of each cell line to differentiate into neural progenitors varied.
Conclusion: Our comparative analysis provides further evidence for similarities and differences between
three hESC lines in self-renewal, and spontaneous and directed differentiation. These differences may be
associated with inherited variation in the sex, stage, quality and genetic background of embryos used for
hESC line derivation, and/or changes acquired during passaging in culture.
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Background
Human embryonic stem cells (hESCs) possess the ability
to self-renew in an undifferentiated state in culture while
retaining the ability to differentiate into all of the cell
types in the human body. These unique capabilities make
hESCs a renewable source of a wide range of cell types for
potential use in research and cell-based drug screening
and therapies for many diseases. These cells have been in
high demand for use in basic and applied biomedical
research. As of January 1, 2006, at least 414 human ES cell
lines have been derived worldwide [1]. Large numbers of
cell lines with genetic diversity are necessary to cover the
vast spectrum of HLA isotypes to avoid transplant rejec-
tion [2,3]. However, many of these cell lines are not fully
characterized and differences among these cell lines are
uncertain [1], although recent studies have revealed simi-
larities and differences among individually developed
human embryonic stem cell lines [3-12].
The comparison of the unique properties and behavior of
each individually derived cell line is critical in identifying the
safe and efficacious lines for research and therapeutic use
[3,13]. It is also essential to understand how the inherited
variation in the sex, stage, quality and genetic background of
embryos, as well as environmental influences such as deriva-
tion methods and passage procedures can affect the ability of
hES cell lines to self-renew and differentiate. Directly com-
paring hES cell lines is challenging since all the genetic, envi-
ronmental and methodological variables complicate the
assessments. Previous studies have attempted setting up a
core set of standard assays to characterize the status of "stem-
ness" and pluripotency [14] and to define a reasonable set of
markers that would serve as reliable indicators for self-
renewal and differentiation of hESCs [10,12]. In the present
study, a side-by-side comparison of the ability to maintain
an undifferentiated state and to self-renew under standard
conditions, the ability to spontaneously differentiate into
cell types of three germ layers in embryonic bodies, and
directed differentiation under neural differentiation-promot-
ing conditions was made between three NIH registered hESC
lines I3, I6 and BG01V. I3 (NIH Registry Name TE03) and I6
(NIH Registry Name TE06) which were derived using rabbit
anti-human whole antiserum with a normal XX and a nor-
mal XY karyotype respectively [15]; BG01V contains known
chromosomal aberrations (XXY, +12 and +17) possesses
characteristics similar to its normal parental line BG01
[16,17]. The hESC lines I3, I6 and BG01V have been exten-
sively characterized and tested in our laboratory for potential
reference standard cell lines, because these three lines repre-
sent consensus standard human ES cell lines and a karyotyp-
ically abnormal human ES cell variant respectively.
Immunocytochemistry, flow cytometry, quantitative RT-
PCR and MPSS were used to assess the self-renewal and
differentiation capabilities. We found that all three cell
lines actively proliferated and expressed similar "stem-
ness" and pluripotency markers and alkaline phosphatase
activity. All the cell lines differentiated into phenotypes
representing ectoderm, endoderm, and mesoderm and
were directed into neural cell lineages in vitro. However,
the significant differences were observed in growth rate,
BrdU incorporation, relative abundance of pluripotency
marker expression and the ability to differentiate. These
differences between the cell lines may depend on a com-
bination of genetic, environmental and methodological
factors [3], implicating the importance of establishing
standard protocols for hESC derivation and culture.
Methods
Cell Culture
Human embryonic stem cell lines I3, I6, and BG01V used
in this study were cultured on mitomycin C-treated mouse
embryonic fibroblasts CF-1 (ATCC, SCRC-1040.2; http://
www.atcc.org). Cells were cultured at 37°C, in a 5% CO2
atmosphere, in the ES medium of Dulbecco's modified
Eagle's medium (D-MEM)/F12 (ATCC 30-2006)80%,
supplemented with 2.0 mM L-alanyl-L-glutamine (ATCC
30-2115), 0.1 mM non-essential amino acids (ATCC 30-
2116), 0.1 mM 2-mercaptoethanol (Sigma Catalog No.
M-7522) and 4 ng/ml basic fibroblast growth factor
(bFGF; R & D Systems Catalog No. 233-FB), 5%; Knock-
out serum replacement (Invitrogen Catalog No. 10828),
15%; fetal bovine serum (ATCC SCRR-30-2020), penicil-
lin (100 I.U./mL) and streptomycin (100 μg/mL) (ATCC
30-2300). An additional 4 ng/ml of bFGF was added in
the first 24 hours after thawing the cells. Daily medium
changes began after the first 48 hours in culture. The
BG01V colony formation was visible within 2–3 days and
the other two cell line's colony formation was observed in
3–4 days. Cells were passaged every 4–5 days using colla-
genase IV (200 Units/mL) (Invitrogen Corporation) for
BG01V, I6 was passaged every 6–7 days and I3 was pas-
saged every 7–8 days.
Embryoid body formation
hESCs in culture were removed from feeder cells using col-
lagenase IV (200 Units/mL) (Invitrogen Corporation;
http://www.invitrogen.com). hESC clusters were trans-
ferred to 10 × 10-cm ultra-low-attachment dishes (corn-
ing; http://www.corning.com) and cultured in medium
D-MEM/F12 (80%) (ATCC 30-2006) supplemented with
ES-Qualified FBS (15%) (ATCC SCRC-30-2020), knock-
out serum replacement (KSR) (5%) (Invitrogen Corpora-
tion), L-alanyl-L-glutamine (2.0 mM) (ATCC 30-2115),
non-essential amino acids (1×) (ATCC 30-2116), β-mer-
captoethanol (0.1 mM) (Invitrogen Corporation), peni-
cillin (100 I.U./mL)/streptomycin (100 μg/mL) (ATCC
30-2300). The medium was changed every second day. To
evaluate the growth rates of EBs, phase-contrast photo-
graphs of EBs were taken and the total areas of EBs wereBMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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measured using Scion Image. The percent increase in total
areas of the cell spheroids was compared between differ-
ent cell lines. Data were calculated as mean ± S.E.M. of at
least 3 separate cultures. The statistical significance was
determined using the Student's t-test with p < 0.05 consid-
ered significant.
Directed neural differentiation of hESCs
The directed neural differentiation method was described
previously [18]. Briefly, colonies of the three hESC lines
I3, I6, BG01V were removed from MEF feeders and disso-
ciated into small clumps by incubating with collagenase
IV (200 Units/ml) (Invitrogen Carlsbad, CA; http://
www.invitrogen.com) at 37°C for 35 minutes. The hESC
clumps were pelleted and cultured in suspension in low
attachment dishes with hESC medium without bFGF for 5
days (the end of this stage is considered as 5 days of differ-
entiation). hESC grew into floating aggregates or embry-
oid bodies (EBs). The neuroectodermal induction began
with EBs transferred into the neural differentiation
medium (NDM) that consisted of two parts of a modified
Eagle's medium (ATCC 30-2002; http://www.atcc.org),
one part F12k- (ATCC 30-2004), 1× N-2 supplement
(Gibco Catalog No. 317740; http://www.invitro
gen.com), 0.1 mM non-essential amino acids (ATCC 30-
2116), penicillin (100 IU/ml)/streptomycin (100 μg/ml)
(ATCC 30-2300) and 5 ng/ml bFGF (R& D Systems Cata-
log No. 233-FB) for 10 days. At days 15–17 of differentia-
tion, EBs were plated on PDL/laminin substrate-coated 35
mm dishes (corning; http://www.corning.com). Although
some neural rosettes were formed in floating embryoid
bodies (EBs), increased rosettes were visualized after plat-
ing of the EBs on substrates. Neuroectodermal cells in
rosettes were further differentiated into neural progenitors
and their progeny on PDL/laminin substrates.
Growth curve
To compare the growth rate between I3, I6 and BG01V, all
three hES cells were plated into 6 well plates containing a
feeder layer of mitomycin C-treated fibroblast (MEF). The
cells were cultured at 37°C in a 5% CO2 atomosphere.
Basic fibroblast growth factor (4 ng/ml) was added to each
cell culture after the first 24 hours. The medium was
changed daily after 48 hours. The cells from three separate
wells were harvested using a 0.25% (w/v) trypsin/0.53
mM EDTA solution (ATCC cat # 30-2101) each day. The
cell counts were performed using Cedex Analysis System,
Innovatis. Data were calculated as mean ± S.E.M. of at
least 3 separate cultures. The statistical significance was
determined using the Student's t-test with p < 0.05 consid-
ered significant.
Bromodeoxyuridine (BrdU) incorporation and 
counterstaining with propidium iodide (PI)
To monitor cell proliferation within colonies of hES cells,
bromodeoxyuridine (BrdU) incorporation with 5-bromo-
2-deoxy-uridine Labeling and Detection Kit I (Roche,
Indianapolis, IN; http://www.roche.com) was used as
described previously [18]. Briefly, cultures were exposed
to 20 μM BrdU for 4 hours and then fixed with 70% alco-
hol containing 50 mM glycine at PH 2.0. After rinsing
with the kit wash buffer, cells were incubated overnight
with mouse anti-BrdU (1:1000) followed by incubation
with FITC-conjugated donkey anti-mouse IgG (1:50)
(Jackson Immunological Research, West Grove, PA) for 45
min. Some cultures that were not exposed to BrdU were
used as negative controls which showed no immunoreac-
tivity, demonstrating the specificity of BrdU antibody. In
order to quantify the cell proliferation rate, cell nuclei
were counterstained by the addition of 5 μg/ml propid-
ium iodide (PI) for 10 min. PI+ and BrdU+ cells were
examined and photographed with Nikon eclipse TE 300
microscope. The proliferation index was defined as the
percentage of BrdU+ nuclei in the total number of PI+
cells. At least 5 labeled colonies were counted from each
dish and three dishes were evaluated. Data were calcu-
lated as mean ± S.E.M. which were statistical significance
determined by using the Student's t-test with p < 0.05 con-
sidered significant.
Immunocytochemistry
For the immunostaining of undifferentiated hES colonies
for "stemness" markers, undifferentiated hESCs were cul-
tured on mitomycin C-treated feeder cells in 35 mm tissue
culture dishes (Corning, Corning, NY, http://www.corn
ing.com). Colonies were rinsed twice before fixation with
4% paraformaldehyde (EMS, Hatfield, PA, http://
www.emsdiasum.com) in 1× PBS for 15 min at room tem-
perature. Cells were permeabilized with 0.5% saponin
(Sigma, St. Louis, MO, http://www.sigma-aldrich.com) in
PBS for 10 min. Primary antibodies against Oct3 (BD Bio-
sciences, San Jose, CA, http://www.bdbiosciences.com,
1:250), NANOG (1:100), and SSEA4 (1:100), and TRA-1-
81 (1:50) (all from Millipore, Billerica, MA http://
www.millipore.com) were incubated with colonies over-
night at 4°C. The secondary antibodies used were either,
Alexa Fluor 488 conjugated goat anti-mouse IgG (H+L),
(Invitrogen/Molecular Probes, Eugene, OR, http://
www.invitrogen.com; 1:50), or FITC-conjugated donkey
anti-Mouse IgM (Jackson ImmunoResearch, West Grove,
PA, http://www.jacksonimmuno.com, 1:50), or Alexa
flour 488-conjugated rabbit anti-goat IgG1 (Invitrogen/
Molecular Probes, Eugene, OR, http://www.invitro
gen.com). Colonies were incubated with secondary anti-
bodies for 45 min at room temperature.
Immunostaining of hESC-derived neural cells for Nestin
and TuJ1 were performed as described previously [18].
Briefly, neural differentiation medium-treated EB were
plated on PDL/laminin coated 35 mm Tissue Culture
plates (Corning, Corning, NY, http://www.corning.com).
Differentiated cells were fixed with 4% paraformaldehydeBMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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and permeabilized in 0.5% saponin as described above.
Primary antibodies used were rabbit anti-nestin, 1:200,
mouse anti-tubulin clone TUJ-1, 1:300, chicken anti-
SOX1, 1:200, (all from Millipore, Billerica, MA http://
www.millipore.com). Secondary antibodies used were
either rhodamine-conjugated donkey anti- rabbit IgG-
(H+L) (Jackson Immunoresearch, West Grove, PA; http://
www.jacksonimmuno.com), Alexa Fluor 488 conjugated
goat anti-mouse- IgG (H+L) (Molecular Probes, Eugene,
Oregon; http://www.invitrogen.com) or FITC-conjugated
donkey anti-chicken IgG (Millipore, Billerica, MA http://
www.millipore.com, 1:50). Cells were counterstained
with the 4'-6-diamidino-2-phenylindole (DAPI) with
dilution of 1:1000 (Sigma; http://www.sig
maaldrich.com). Immunofluorescence signals were
observed and photographed with a Nikon TE 300 epiflu-
orescence microscope (Nikon, Inc. Melville, NY)
equipped with a Qicam FAST1394 digital camera (Surrey,
BC, Canada) and Openlab vs. 4.0.4 software http://
www.improvision.com.
To quantify the percentage of hESC-differentiated neural
progenitors, cell counting was performed on cultures
immunostained for nestin, together with nuclear DAPI
(A-C) Morphology of undifferentiated colonies of hESC lines I3, I6, and BG01V Figure 1
(A-C) Morphology of undifferentiated colonies of hESC lines I3, I6, and BG01V. Phase contrast photographs of 
hESC colonies cultured on mouse embryonic fibroblast feeders for 4 days. The boxes in the center of the colonies indicate 
areas shown in A1-C1. (A1-C1) High magnification of the center regions of the colonies from each cell line showing distinct 
morphologies. The colonies of BG01V and I6 lines exhibit highly compact cells with rather vague borders (A1 and C1), while I3 
colonies have a mosaic appearance with loosely packed cells (B1). Bars in A and A1 = 100 μm. (D) Three human embryonic 
stem cell lines display distinct growth characteristics under the same culture conditions. The growth curves show significant 
differences in percent increase in the number of cells at day 6 in culture between the three cell lines. I3 cells grow slower than 
the other two cell lines and have a tendency to differentiate. Therefore, it is more difficult to maintain the I3 cell line in an 
undifferentiated state. In contrast, the I6 and BG01V cell lines grow faster and are passaged 2–3 days earlier than the I3 cells. 
Statistical differences for percent increases in cell numbers at 6 days between the BG01V or I6 and I3 are significant ** p < 
0.01.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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counterstaining, in 35 mm culture dishes coated with dif-
ferent laminin substrates from at least three independent
experiments. All data were expressed as mean ± SEM, and
Student's t test was used for statistical evaluation. In all
instances p < 0.05 was considered statistically significant.
Alkaline Phosphatase staining
Endogenous alkaline phosphatase activity in BG01V, I3
and I6 cells was detected using the ELF® 97 Endogenous
Alkaline Phosphatase Detection Kit (ATCC catalog #
SCRR-3010) according to the manufacturer's instructions.
Cells cultured in 6 well plates (Corning Life Sciences;
http://www.corning.com) were treated with 4% parafor-
maldehyde for 15 minutes at room temperature. The cells
were washed with 1× PBS, treated with 0.2% Tween-20 for
10 minutes at room temperature and rinsed with 1× PBS.
Fixed cells were then incubated with a filtered 1:20 dilu-
tion of the phosphatase substrate in situ, and the reaction
was monitored using an epifluorescence microscope. The
reaction was terminated using a stop solution consisting
of PBS, 25 mM EDTA, 5 mM levamisole, pH 8.0. Cells
were rinsed with PBS before mounting on glass micro-
scope slides.
qRT-PCR
Total RNA was isolated from three hESC lines I3, I6, and
BG01V using an RNAeasy Plus Mini kit (Qiagen catalog
NO 74134; http://www1.qiagen.com/). The isolated
RNAs were quantified using a RNA 6000 Nano Kit (Cata-
log NO 5067-1511). The integrity of RNA was checked on
Agilent 2100 Bioanalyzer (Agilent Technologies; http://
www.chem.agilent.com part No G2940CA). Equal
amounts of RNA (1 μg) was taken for all samples and
reverse transcription was done using RT2 First Strand kit
from Superarray Biosciences (SuperArray, catalog No C-
03; http://www.superarray.com. The total volume of the
reaction was 20 μL and was diluted to 100 μL. PCR reac-
tions were performed using a ABI Fast 7900 using RT2
Real-Time™ SYBR Green PCR master mix PA-012 and qRT-
PCR primers from SuperArrray Biosciences. The total vol-
ume of the PCR reaction was 10 μL. The qRT-PCR Primers
sets catalog numbers are 18srRNA PPH00073A, B-actin
PPH05666A, POU5F1, Nanog, UTF1 (undifferentiated)
PPH02394A, PPH02391A and PPH17032A, keratin C and
NEFL (ectoderm) PPH-21369A and PPH02430A, alpha-
globin and Beta-globin (Mesoderm) PPH09054A and
PPH12971A, alpha-1AT PPH02413A, nestin and Musashi
1, SOX1 (Neural Progenitor) PPH02388A, PPH13090A
and PPH02390A, MAP2, GAD-65 (Neural) PPH02419A,
PPHo5950A, S100B and GFAP (astrocytes) PPH02408A
and PPH02472A; http://www.superarray.com. The ther-
mocycler parameters were 95°C for 10 min, followed by
40 cycles of 95°C for 15 sec and 60°C for 1 min. Each
gene for each sample was run in quadruplicate. Relative
changes in gene expression were calculated using the ΔΔCt
(threshold cycle) method. This method first subtracts the
ct (Threshold cycle number) of the gene-avg ct of the two
house keeping genes (18srRNA and ACTB) to normalize
to the RNA amounts. Finally, the delta delta ct is calcu-
lated by subtracting the normalized average ct of the
treated cells from the normalized average ct of the undif-
ferentiated cells. Then this delta ct is raised to the negative
power of 2 in order to calculate the fold change [19].
Massively Parallel Signature Sequencing
Massively parallel signature sequencing (MPSS) was per-
formed using 1–2 μg purified total RNA from each of the
three human ESC lines (BG01V, I3 and I6) from undiffer-
entiated cells (day 0) and cells at different stages of differ-
entiation (days 7, 14 and 21); the presence and absence of
ESC markers and markers of differentiation were evalu-
ated. The quality of total RNAs was evaluated using an
Agilent Bioanalyzer. mRNA isolation was processed
according to the MPSS protocol as described previously
[20] with some modification. In brief, the mRNA was
reverse-transcribed, the cDNA synthesized and digested
with DpnII, then GEX adaptors ligated with DpnII and
amplified by PCR, the cDNA library was ready to
sequence. The abundance for each signature was con-
verted to transcripts per million (tpm) for the purpose of
comparison between samples. Only reliable and annotat-
able signatures against updated human signature database
were considered for further analysis.
To generate a complete, annotated human signature data-
base, all the possible signatures from the human genome
Digital gene expression of the three undifferentiated hESC  lines Figure 2
Digital gene expression of the three undifferentiated 
hESC lines. It shows that around 92% (10057 out of 10945) 
of the genes expressed in the I3 cells were also expressed in 
the BG01V and I6 cells. The large overlap in genes expressed 
among the 3 hESC lines suggests the presence of a relatively 
stable core "stemness" transcriptome.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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sequence, the human UniGene sequences, and human
mitochondrion were extracted. Each virtual signature was
ranked based on its position and orientation in the origi-
nal sequence. The annotation database is established
based on the virtual signatures, their classes and their cor-
responding genes so that each signature only has one cor-
responding annotation. The database is then used to
annotate the data from the experiment.
Results
Different hESC lines exhibit different colony morphologies
Undifferentiated hESC lines BG01V, I3 and I6 that had
been maintained on mitomycin C-treated mouse embry-
onic fibroblasts (MEF) for 4–5 days displayed distinct cell
colony morphologies. Cells in the center regions of colo-
nies exhibited prominent nucleoli and a high nucleus to
cytoplasm ratio. Cells from BG01V (passage 22) and I6
(passage 50) lines were highly compact with rather vague
borders (Figure 1A and 1A1, 1C and 1C1). Their colonies
exhibited a round and sharp edge separating the hESC
from surrounding feeder cells. In contrast, colonies of I3
cell line (passage 58) exhibited a mosaic appearance with
loosely packed cells (Figure 1B and 1B1). This observation
is consistent with previous descriptions [21,22].
Differences in growth curves between undifferentiated 
hESC lines
To examine potential differences in the ability to self-
renew between the three hESC lines, the percent increase
in cell numbers relative to cell numbers at day 1 were cal-
culated up to 6 days (Figure 1D). The relative growth was
determined, followed by the plating of approxmately 105
Differences in relative expression levels of undifferentiated cell ("stemness") markers among the three undifferentiated hESC  lines Figure 3
Differences in relative expression levels of undifferentiated cell ("stemness") markers among the three undif-
ferentiated hESC lines. (A) Immunofluorescent staining of hESC colonies shows an expression of Oct3/4, NANOG, SSEA4, 
TRA-1-81 and alkaline phosphatase (AP) activity in all three cell lines. Bar = 100 μm. (B) Quantitative RT-PCR analysis of the 
relative expression levels of "stemness" genes (NANOG, POU5F1, and UTF1) in three undifferentiated hES cells. The Y-axis 
plots the fold change of the undifferentiated cell lines in comparison to the undifferentiated I3 cell lines. The expression level of 
the undifferentiated genes implicates that the I3 hES cells express much less "stemness" (undifferentiated) genes than the I6 and 
BG01V cell lines. (C) MPSS analysis shows the consistency of the expression levels of the undifferentiated genes (Nanog, 
POU5F1, and UTF1) compared with the results of the qRT-PCR analysis (B).BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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cells on a MEF feeder, and trypsinized cells were counted
using a Cedex Analysis System. The differences in the cell
number between each cell lines should represent the dif-
ferences in relative growth of hESCs since the fibroblast
feeder cells were mitomycin C-treated. The growth curves
in Figure 1D show significant differences in percent
increase in the number of cells at day 6 in culture between
the three cell lines. I6 and BG01V cell colonies reached an
average size of 300–400 cells for splitting at 5–6 days after
passaging. In contrast, I3 cells grew slower than the other
two cell lines and were not ready to passage until culture
day 8. It appeared more difficult to maintain the I3 cell
line in an undifferentiated state since it had more ten-
dency to differentiate.
MPSS expression analysis of three human ESC lines
After full annotation of over one million sequenced signa-
tures from each ESC line, there were 28, 071 human Uni-
Gene clusters detected by MPSS in the three human
undifferentiated ESC lines (BGO1V, I3 and I6). I6
expressed the most genes (25,862) and I3 expressed the
fewest genes (10, 945); BGO1V cells expressed 19, 858.
Although the differences in numbers of total expressed
gene numbers among the three ESC lines was significant,
Differences in the proliferation rate between the undifferentiated I3, I6 and BG01V cells Figure 4
Differences in the proliferation rate between the undifferentiated I3, I6 and BG01V cells. All three cell lines were 
maintained on the MEF for 4 days post-passaging under the same culture conditions. A four hour BrdU pulse shows significant 
differences in the proliferation index which is defined as the percentage of BrdU+ nuclei among the total number of propidium 
iodide (PI)+ cells.(A-I) Images of the three cell line colonies (A, D, G) immunostained for BrdU incorporation (C, F, I) and 
counterstained with PI (B, E, H). Bars in A, D and G = 100 μm. (J) Bar plot summarizing the differences in diameters of the col-
onies between the three cell lines. Values are expressed as a percent of the total number of cells (mean ± SEM; BG01V- 554 ± 
187 μm, I3 – 184 ± 75 μm, and I6 – 488 ± 165 μm. Sizes of colonies derived from the BG01V or I6 cells are significantly greater 
than those derived from the I3 cells. ** p < 0.01. (K) Bar plot summarizes the differences in the BrdU incorporation levels 
between three cell lines. The BG01V cells maintained on MEF at 4 days post-passaging exhibit the highest BrdU incorporation 
levels and the I3 exhibited the lowest levels. Values are expressed as the ratio of BrdU+ cells to the total number of cells (PI 
stained) (mean ± SEM). Statistical differences for colony diameters or BrdU/PI % between the I6 or BG01V and the I3 cells are 
significant * p < 0.05.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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the number of core transcriptome expression of the three
hESC lines were substantial: 95.7% (10479/10945) and
93.3% (10210/10945) of I3 genes were expressed in I6
and BGO1V, respectively, and 92% (10,057 out of 10,
945) genes of I3 were co-expressed in the other two lines
(Figure 2). These findings indicate that different hESC
lines retain core transcriptome features of embryonic
"stemness".
All undifferentiated hESC lines express pluripotency 
markers, but their gene expression levels are variable
The undifferentiated state of human ES cells was first char-
acterized by immunocytochemistry. All the three hESC
lines expressed glycolipid antigens such as stage-specific
embryonic antigen SSEA-4, tumor rejection antigen TRA-
1-81, and transcription factors Oct-3/4 and NANOG as
described previously [23]. All cell lines also exhibited
alkaline phosphatase (AP) activity (Figure 3A). To further
study the quantitative expression of pluripotency markers,
quantitative RT-PCR and MPSS were used to assay the
expression of a series of genes in each of the three undif-
ferentiated hESC lines (Figure 3B) and in their differenti-
ated EB. We cross validated the results of quantitative RT-
PCR and MPSS analysis of the expression levels of undif-
ferentiated hESC marker genes (NANOG, POU5F1, and
UTF1) in the three hESC lines over time.
The Y-axis plots the fold change of the undifferentiated I6
and BGO1V cell lines in comparison to the undifferenti-
ated I3 cell line. The expression level of the undifferenti-
ated genes implicates that the I3 hES cells express much
lower levels of "stemness" (undifferentiated) genes com-
pared to the I6 and BG01V cell lines (Figure 3B and 3C).
Differences in BrdU incorporation between 
undifferentiated I3, I6 and BG01V cells
To examine the potential difference in the ability to pro-
liferate between different the hESC lines, bromodeoxyuri-
dine (BrdU) incorporation assays were performed in
colonies of I3, I6 and BG01V cells (Figure 4A, D, G). hESC
Differences in the embryoid body (EB) growth rates between the hESC lines I3, I6 and BG01V Figure 5
Differences in the embryoid body (EB) growth rates between the hESC lines I3, I6 and BG01V. hESC colonies 
were removed from feeder monolayers and grown in low attachment dishes. (A) Phase contrast images of the EBs in the three 
cell lines cultured in suspension for 10 days. (B) A plot showing differences in the EB growth rate between three cell lines. The 
growth rate of EBs was calculated by the increase of EB size (total EB area) in each 5 days from day 1 though 25. Values are 
expressed as percent increase in total areas of EBs (mean ± SEM). Statistical differences for EB growth rates after 10 days in 
culture between I3 and I6 or BG01V are significant * p < 0.05. Bar in upper panel = 200 μm.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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maintained on the MEF for 4 days under the same condi-
tions were incubated with BrdU for 4 h before being proc-
essed for BrdU immunocytochemistry (Figure 4C, F, I).
Cells were counterstained with PI which stained nuclei of
all cells (Figure 4B, E, H). We indexed proliferation for
each cell line by quantifying the proportion of BrdU+ cells
versus the total number of cells (PI-stained cells). At 4
days post-passaging, all three cell lines showed active
DNA synthesis, but the I3 cell line exhibited significantly
smaller colonies and a lower proliferation rate compared
to the other two cell lines (Figure 4J). Unlike the I6 and
BG01V cell colonies within which BrdU+ cells were con-
fined, some BrdU+ cells were scattered outside of the I3
colonies, although the majority of BrdU+ cells were
located within the colonies (Figure 4F). The scattered
BrdU+ cells may represent individual proliferative I3 cells
on the MEF layer before forming a colony, indicating
much slower proliferation in the I3 cells compared to the
I6 and BG01V cells. Cell counting showed differences in
BrdU incorporation between the three cell lines. BG01V
cells exhibited highest BrdU incorporation levels (88% ±
12%), while I3 cells had the lowest levels (62% ± 3.1%)
Differences in expression of three germ layer markers in the embryoid bodies (EBs) derived from three hES cell lines BG01V,  I3 and I6 Figure 6
Differences in expression of three germ layer markers in the embryoid bodies (EBs) derived from three hES 
cell lines BG01V, I3 and I6. (A) Quantitative RT-PCR analysis of expression of keratin C (ectoderm marker) and alpha-
Globin (mesoderm marker) at 7 and 14 days in the EBs derived from the three cell lines. The Y-axis plots the fold changes (log 
scale) in expression levels of the two genes for each cell line when compared to its own undifferentiated levels at Day 0. The 
I3-derived EBs cultured at days 7 and 14 expressed markedly higher levels of the two genes compared to I6 and BG01V-
derived EBs. (B and C) Higher expression of endoderm marker AFP and mesoderm marker IGF-2 gene expression in the I3 
than in the BG01V and I6 cell lines revealed by MPSS. Quantitative MPSS analysis of the AFP and IGF-2 in the EBs derived from 
the hES cell lines BG01V, I3 and I6. The Y-axis plots the fold change (log scale) in expression levels for each cell line when com-
pared to its own undifferentiated cells (Day 0).BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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(Figure 4K). The proliferation rate in I6 cells was 78% ±
9.2%. The difference between three cell lines in BrdU
incorporation was consistent with the sizes (diameters) of
the colonies. At 4 days in culture I3 cells exhibited smaller
colonies with a lower proliferation index compared to the
BG01V and I6 cells. Colonies of the I6 and BG01V cells
exhibited higher numbers of active DNA synthesizing
cells compared to the I3 cells.
Embryoid body formation and growth rate vary among the 
three hESC lines
EB represents a unique tool to investigate in vitro differen-
tiation processes of hESCs. Colonies of the three ESC lines
were removed from feeder cells and grown as cell aggre-
gates in a suspension in low attachment dishes without
basic fibroblast growth factor. The growth rate of the EBs
was calculated by the increase of EB size (total EB area) in
every 5 days period from days 1 though 25 (Figure 5A).
The percent increase in size of the cell spheroids was sig-
nificantly different in the EBs from the three different
hESC lines after 10 days in the suspension culture (Figure
5B). The relative EB growth was greater in the I3 and
BG01V cells compared to the I6 cells.
All three hESC lines are able to differentiate into cells 
expressing markers of all three germ layers and neural cells
EB formation is a model of in vitro embryogenesis in
which all three primary embryonic germ cell lineages are
generated [24]. To examine differences in the gene expres-
sion of the three germ layer markers in EBs derived from
Quantitative RT-PCR analysis shows differences in expression levels of neural cell lineage-specific genes between three hES cell  lines Figure 7
Quantitative RT-PCR analysis shows differences in expression levels of neural cell lineage-specific genes 
between three hES cell lines. The Y-axis plots the fold change for each cell line when compared to its own undifferentiated 
cells (Day 0). (A) shows a comparison of expression levels of the neural progenitor-specific genes at days 7, 14 and 21 of differ-
entiation. The I3 and I6 cells exhibited higher levels of Nestin and Musashi 1 gene expression than BG01V cells. (B) shows a 
comparison of the expression levels of the neuronal (MAP2)- and glial (S100B)-specific genes at days 7, 14 and 21 of differenti-
ation. Both of the MAP2 and S100B gene expressions were up-regulated in the I3 and I6 cells.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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three ESC lines, we assessed the expression of keratin C
(ectoderm) and alpha-globin (mesoderm) by qRT-PCR
(Figure 6A), and expression of alpha FP (endoderm) and
IGF2 (mesoderm) by MPSS (Figure 6B, C). The fold
changes (log scale) in the expression levels of keratin C
and alpha-Globin for each cell line relative to its own
undifferentiated levels showed that the I3 cell line
expressed markedly higher levels of these two genes at 7
and 14 days when compared to the I6 and BG01V cell
lines (Figure 6A). MPSS results showed that the I3 cell line
expressed higher levels of both Alpha FP and IGF-2 than
the I6 and BG01V cell lines (Figure 6B, C).
Since a primitive neural stem cell stage can be acquired
though a default mechanism [25], we assessed the expres-
sion levels of the neural markers, Nestin and Musashi 1
(neural progenitor), MAP2 (mature neurons) and S100B
(astrocytes) by qRT-PCR and MPSS (Figure 7). qRT-PCR
analysis showed differences in expression levels of these
genes between the three hES cell lines. The I3 and I6 cells
The comparison of the neural progenitor derivation from the I3, I6 and BG01V hESC lines over time under the same neural dif- ferentiation-promoting condition Figure 8
The comparison of the neural progenitor derivation from the I3, I6 and BG01V hESC lines over time under the 
same neural differentiation-promoting condition. (A) The protocol used to direct hESCs into neural cell lineages. (B-E) 
Phase contrast images show the progression of the neural induction of hESCs in which the hESC colonies (B) were removed 
from the MEF feeders and grown into floating aggregates or embryoid bodies (EBs) (C). Neural rosettes (D) were induced by 
the neural differentiation medium. New cells constantly generated and migrated radially away from the center of the EB and 
formed a rim of cells (E). Bars in B-E = 100 μm. (F-H) Neural progenitors derived from the I3 cell line. Phase contrast image of 
I3-differentiated cells (F) were immunostained for nestin (H) and nuclear counterstained with DAPI (G). (I) The plot shows sig-
nificant differences in the average percent increase in the number of nestin+ cells differentiated from the three cell lines. Values 
are expressed as percent increase in Nestin+ neural progenitors (mean ± SEM). Statistical analysis shows that the percent 
increase in number of Nestin+ cells generated from the I3 or I6 cells is significantly greater than that generated from BG01V 
cells, * p < 0.05. Bar in upper panel = 200 μm.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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expressed higher levels of neural progenitor-specific genes
(Nestin and Musashi) (Figure 7A), as well as neuronal
gene (MAP2) and glial gene (S100B) (Figure 7B) than
BG01V cells. Both MAP2 and S100B genes were upgraded
from day 7 to Day 21 in culture in the I3 and I6 cells.
Differences in expression of neural phenotypes and genes 
in directed neural differentiation between three hESC lines
Differences in pluripotency between the three cell lines
were also examined during the directed neural differenti-
ation. To test the possible differences we used a reliable
step-wise differentiation protocol (Figure 8A) which gen-
erated highly pure neural progenitors from the I3 and I6
cells [18]. The hESC colonies were removed from MEF
feeders and cultured in suspension in low attachment
dishes with hESC medium without bFGF for 5 days (Fig-
ure 8B, C). Differentiating EBs were transferred into the
neural differentiation medium for 10 days. At days 15–17
of differentiation, EBs were plated on poly-D-lysine/lam-
inin-coated 35 mm dishes. Neural rosettes were visualized
after plating of the EBs on the substrate (Figure 8D). Neu-
roectodermal cells in neural rosettes were stained for Sox1
and Nestin (not shown), and further differentiated into
neural progenitors and their progeny (Figure 8E). Under
the same neural differentiation-promoting condition, we
quantified the percentage of hESC-differentiated neural
Difference in directed neural differentiation between hESC lines I3, I6 and BG01V Figure 9
Difference in directed neural differentiation between hESC lines I3, I6 and BG01V. Two days after transferring EBs 
to a poly-D-lysine/laminin substrate, parallel immunocytochemistry and quantitative RT-PCR were performed in hESC-derived 
cell populations. Immunofluorescent staining for Nestin (A-F) shows that both the I3 and the I6 cells differentiate into the 
enriched Nestin+ neural progenitors while BG01V cells barely generate Nestin+ cells. Bars in A-C = 100 μm. (G) qRT-PCR 
analysis of the gene expression of the neural progenitor markers SOX1 and MSI1, mature neuronal marker MAP2, and astro-
cyte marker GFAP among the three cell lines at day 17 of differentiation. The Y-axis represents the fold changes of the gene 
expression for each cell line when compared to its own undifferentiated levels at day 0. The relative levels of these genes 
expressed by the I3 and I6 cells are higher than those expressed by BG01V cells.BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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progenitors by immunostaining for Nestin, together with
nuclear DAPI counterstaining (Figure 8F, G, H). Nestin+
cells were manually counted and were expressed as a per-
centage of the total DAPI labeled cells (Figure 8I). A signif-
icant difference was found in the percentage increase in
number of Nestin+ cells differentiated from the three cell
lines after 3 days post plating (Figure 9A–F). The percent-
age increase in Nestin+ cells generated from the I3 cells
was greater than that of the I6 cells. The BG01V generated
undetectable or an insignificant number of neural progen-
itors which were lightly scattered among differentiated
cells. In addition, we tracked the appearance of neural
rosettes during neural differentiation and found that the
I3-derived rosettes were generated 5–9 days earlier than
the I6-derived neural rosettes. The BG01V-derived neural
rosettes were barely detected.
To assess differences in the gene expression during neural
differentiation between the three cell lines, total RNA was
harvested from the EBs at 2 days post plating on poly-D-
lysine/laminin substrates. The qRT-PCR analysis of the
expression levels for the neural progenitor markers SOX1
and MSI1, the mature neuron marker MAP2, and the
astrocyte marker GFAP showed that the all these genes
were strongly expressed in the I3 cells (Figure 9G). The Y-
axis plots the fold changes of gene expression for each cell
line when compared to its own undifferentiated levels at
Day 0. The high levels of expression for the neural progen-
itor genes SOX1 and MSI1 in the I3 and I6 cells were con-
sistent with their high expression of nestin
immunoreactivity (Figure 9A, B).
Discussion
In the present study, we demonstrated that although all
the three hESC lines I3, I6 and BG01V can maintain their
ability to proliferate and give rise to the progeny of the
three embryonic germ layers, their self-renewal and differ-
entiation capabilities are variable. The overall gene expres-
sion profiles of the three lines were similar; however, in
most cases, the relative abundance of expression of the
same "stemness" and differentiation genes were highly
variable between the cell lines. We also found that under
the same neural induction conditions, the ability of each
of the three lines to differentiate into neural progenitors
was also distinct. Previous studies that compared hESC
lines focused on the expression of pluripotency and the
differentiation marker genes [9,10,12,26]. In the present
study, in addition to the variable gene expression in undif-
ferentiated and EB differentiated states, we detected a pro-
found variation in the cell growth rate, BrdU
incorporation and the directed neural differentiation.
The work presented here is part of continuing efforts to
develop a database of the properties and behaviors of dif-
ferent hESC lines and to understand the similarities and
differences between individual hES cell lines by side-by-
side comparison. This comparative analysis of individu-
ally-derived hESC lines is critical, because the properties
and behavior of each line are uniquely shaped by their
histories. It has become clear that different derivations
produce hESC lines that are similar with regards to "stem-
ness", but with inherent differences in gene expression,
methylation status, X chromosome inactivation, rate of
self-renewal and the ability to differentiate [6,26,27].
More importantly, the behavior of cells and their overall
state changes as culture conditions and the stress they are
subjected to is altered, and permanent genomic changes
frequently occur as passage numbers increase [28-30].
Variability in genetic, environmental and methodological
factors has led to a great difficulty in comparing results of
studies of the hESC lines among laboratories.
In this study, our side-by-side comparison between the
three hESC lines was made under the same culture condi-
tions in an effort to minimize the influences of environ-
mental and methodological factors. The differences we
found between the three cell lines may be due to the
genetic variation and epigenetically inherited alterations
from previous culture history. Lines I3 and I6 were derived
in the same laboratory but differ in sex [15]. BG01V is a
variant cell line with an abnormal karyotype [17].
Another factor that may contribute to the cell line differ-
ences is the variation in passage number between the
three cell lines. It is more challenging to directly compare
differences in directed differentiation between different
human ES cell lines because the differentiation protocols
most likely are cell line-specific. Previous study has shown
that the reliable dopaminergic differentiation was
induced by co-culture with the mouse stromal cell line
PA6 [16]. However, in the present study, under culture
conditions that favored neural differentiation of the I3
and I6 cells, the BG01V barely produced neural progeni-
tors and expressed much fewer neural-specific genes com-
pared to I3 and I6 cells. The inconsistency in BG01V cell
neural differentiation data between Zeng's and our studies
points out that each hES cell line needs an optimized pro-
tocol for a specific phenotype differentiation.
hESC lines have a great potential to provide new research
tools that support clinical applications. The frequency of
non-obvious changes in the hESC behavior and potency is
of great concern for the future of cell replacement thera-
pies. Physicians who transplant hESC-derived cells into
patients must be in confident as to the safety and stability
of the cells they use. Thus it is necessary not only to estab-
lish a set of characterization tests which are sensitive
enough to detect small but harmful changes, but these
tests must also be simple and inexpensive enough to be
used routinely. The comparison made in this study also
shows that the individually derived hESC lines from dif-BMC Cell Biology 2009, 10:44 http://www.biomedcentral.com/1471-2121/10/44
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ferent laboratories are variable to various extents. There-
fore reference standards, such as cell lines that provide
consistent, predictable results and are not difficult to cul-
ture are needed. We believe that the database of hESC
characterization data and standard reference materials
will permit the research community to readily monitor
and compare hESC lines.
Conclusion
Our side-by-side comparison confirms the general finding
that hESC lines share the properties of self-renewal,
expression of "stemness" and pluripotency markers and
the ability to differentiate, but many differences remain
between cell lines. These differences include the ability to
maintain an undifferentiated state, to self-renew, and to
differentiate. In addition to inherited variation in the sex,
stage, quality and genetic background of embryos used for
hESC line derivation, these differences may be associated
with derivation methods and changes acquired during
passaging in culture. To this end, it is important to set up
standards shared by multiple laboratories for routine
analysis of undifferentiated state ("stemness"), identity,
stability, pluripotency and sterility of hESC lines.
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